Labeling strategies of peptides with 18F for positron emission tomography

Current Topics in Medicinal Chemistry

Volumn 10, Issue 16, 2010, Pages 1669-1679

  Olberg, D E ^a   Hjelstuen, O K ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b GE HEALTHCARE   (Norway)

Author keywords

Fluorine 18; Labeling; Peptide; PET; Prosthetic group; Radiosynthesis

Indexed keywords

1 [3 (2 FLUOROPYRIDIN 3 YLOXY)PROPYL]PYRROLE 2,5 DIONE F 18; 2 BROMO N [3 (2 FLUOROPYRIDIN 3 YLOXY)PROPYL]ACETAMIDE F 18; 2 DEOXY 2 FLUOROGLUCOPYRANOSIDE F 18; 2 DEOXY 2 FLUOROGLUCOSYL AZIDE F 18; 2 FLUORO 3 PENT 4 YN 1 YLOXYPYRIDINE F 18; 2 FLUORO 3,4,5,6 TETRAHYDROXYHEXANAL O [3 (2,5 DIOXO2,5 DIHYDROPYRROL 1 YL)HEXYL]OXIME F 18; 2 FLUOROETHYLAZIDE F 18; 4 (3 FLUOROPROPOXY)BENZALDEHYDE F 18; 4 (DI TERT BUTYLFLUOROSILYL)BENZALDEHYDE F 18; 4 FLUORO 1 BUTYNE F 18; 4 FLUORO N (PROP 2 YNYL)BENZAMIDE F 18; 4 FLUOROBENZALDEHYDE F 18; 4 FLUOROPHENACYLBROMIDE F 18; 6 FLUORO 1 HEXYNE F 18; ARGINYLGLYCYLASPARTIC ACID F 18; FLUORINE 18; FLUOROBENZALDEHYDE F 18; FLUORODEOXYGLUCOSE F 18; FLUORODEOXYGLUCOSE MALEIMIDEHEXYLOXIME F 18; FLUORONICOTINIC ACID TETRAFLUOROPHENYL ESTER F 18; N (4 FLUOROBENZYL) 2 BROMOACETAMIDE F 18; N SUCCINIMIDYL 4 FLUOROBENZOATE F 18; N [2 (4 FLUOROBENZAMIDO)ETHYL]MALEIMIDE F 18; N [6 (4 FLUOROBENZYLIDENE)AMINOOXYHEXYL]MALEIMIDE F 18; O (2 DEOXY 2 FLUORO DEXTRO GLUCOPYRANOSYL) LEVO SERINE F 18; O [2 (2 FLUOROETHOXY)ETHYL] N METHYL N HYDROXYLAMINE F 18; PROPARGYL 4 FLUOROBENZOATE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; [2 [2 [2 (2 FLUOROETHOXY)ETHOXY]ETHOXY]ETHOXY]ACETALDEHYDE F 18;

ARTICLE; CYCLOADDITION; DRUG SYNTHESIS; ELECTRON TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; RADIOCHEMISTRY;

EID: 77957999990     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802610793176747     Document Type: Article

References (119)

1. Schottelius, M.; Wester, H.-J. Molecular imaging targeting peptide receptors. Methods, 2009, 48, 161-177.
2. Lundqvist, H.; Tolmachev, V. Targeting peptides and positron emission tomography. Peptide Sci., 2002, 66, 381-392.
3. +-emitting compounds based on fluorine-18. Top. Curr. Chem., 2002, 222 (Contrast Agents II), 201-258.
4. Nayak, T. K.; Brechbiel, M. W. Radioimmunoimaging with longerlived positron-emitting radionuclides: Potentials and challenges. Bioconjug. Chem., 2009, 20, 825-841.
5. McQuade, P.; Rowland, D. J.; Lewis, J. S.; Welch, M. J. Positronemitting isotopes produced on biomedical cyclotrons. Curr. Med. Chem., 2005, 12, 807-818.
6. Papash, A. I.; Alenitsky, Y. G. Commercial cyclotrons. Part I: Commercial cyclotrons in the energy range 10-30 MeV for isotope production. Phys. Part. Nucl., 2008, 39, 597-631.
7. 18Flabeled radiopharmaceuticals for PET in oncology, excluding FDG. Nucl. Med. Biol., 2000, 27, 103-112.
8. 18F]fluorobenzoyland 2- [18F]fluoropropionyl-peptides. J. Med. Chem., 2008, 51, 5901-5904.
9. Blok, D.; Feitsma, R. I. J.; Vermeij, P.; Pauwels, E. J. K. Peptide radiopharmaceuticals in nuclear medicine. Eur. J. Nucl. Med., 1999, 26, 1511-1519.
10. Wester, H.-J. Molecular targeting with peptides or peptide polymer conjugates: Just a question of size? J. Nucl. Med., 2005, 46, 1940-1945.
11. Elsinga, P. H. Radiopharmaceutical chemistry for positron emission tomography. Methods, 2002, 27, 208-217.
12. Zaccaro, L.; Gatto, A. d.; Pedone, C.; Saviano, M. Peptides for tumour therapy and diagnosis: Current status and future directions. Curr. Med. Chem., 2009, 16, 780-795.
13. 99mTc labeling of highly potent small peptides. Bioconjug. Chem., 1997, 8, 621-636.
14. Mawlawi, O.; Townsend, D. Multimodality imaging: an update on PET/CT technology. Eur. J. Nucl. Med. Mol. Imaging, 2009, 36, 15-29.
15. Dijkgraaf, I.; Beer, A. J.; Wester, H.-J. Application of RGDcontaining peptides as imaging probes for alphavbeta3 expression. Front. Biosci., 2009, 14, 887-899.
16. Cheng, D.; Yin, D.; Zhang, L.; Wang, M.; Li, G.; Wang, Y. Preparation of the novel fluorine-18-labeled VIP analog for PET imaging studies using two different synthesis methods. J. Fluorine Chem., 2007, 128, 196-201.
17. Yagle, K. J.; Eary, J. F.; Tait, J. F.; Grierson, J. R.; Link, J. M.; Lewellen, B.; Gibson, D. F.; Krohn, K. A. Evaluation of 18Fannexin V as a PET imaging agent in an animal model of apoptosis. J. Nucl. Med., 2005, 46, 658-666.
18. Okarvi, S. M. Peptide-based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases. Med. Res. Rev., 2004, 24, 357-397.
19. 18F-labelled linear peptides. Eur. J. Nucl. Med. Mol. Imaging, 2002, 29, 754-759.
20. Ozker, K. Current developments in single photon radiopharmaceuticals for tumor imaging. Curr. Pharm. Des., 2000, 6, 1123-1126.
21. Schottelius, M.; Laufer, B.; Kessler, H.; Wester, H.-J. Ligands for mapping v 3-integrin expression in vivo. Acc. Chem. Res., 2009, 42, 969-980.
22. Liu, S. Radiolabeled cyclic RGD peptides as integrin vb3-targeted radiotracers: Maximizing binding affinity via bivalency. Bioconjug. Chem., 2009, 20, 2199-2213.
23. Haubner, R.; Decristoforo, C. Radiolabelled RGD peptides and peptidomimetics for tumour targeting. Front. Biosci., 2009, 14, 872-886.
24. 18F-FPRGD2): synthesis and microPET imaging of alphav beta3 integrin expression. Eur. J. Nucl. Med. Mol. Imaging, 2007, 34, 1823-1831.
25. 18F-labeled PEGylated RGD peptide. Eur. J. Nucl. Med. Mol. Imaging, 2004, 31, 1081-1089.
26. Hausner, S. H.; Abbey, C. K.; Bold, R. J.; Gagnon, M. K.; Marik, J.; Marshall, J. F.; Stanecki, C. E.; Sutcliffe, J. L. Targeted in vivo imaging of integrin v 6 with an improved radiotracer and its relevance in a pancreatic tumor model. Cancer Res., 2009, 69, 5843-5850.
27. Edwards, C. M. B.; Cohen, M. A.; Bloom, S. R. Peptides as drugs. QJM, 1999, 92, 1-4.
28. Zannetti, A.; Del Vecchio, S.; Iommelli, F.; Del Gatto, A.; De Luca, S.; Zaccaro, L.; Papaccioli, A.; Sommella, J.; Panico, M.; Speranza, A.; Grieco, P.; Novellino, E.; Saviano, M.; Pedone, C.; Salvatore, M. Imaging of v 3 Expression by a bifunctional chimeric RGD peptide not cross-reacting with v 5. Clin. Cancer Res., 2009, 15, 5224-5233.
29. Wester, H.-J.; Schottelius, M.; Poethko, T.; Bruus-Jensen, K.; Schwaiger, M. Radiolabeled carbohydrated somatostatin analogs: A review of the current status. Cancer Biother. Radiopharm., 2004, 19, 231-244.
30. 18f-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography. Clin. Cancer Res,. 2004, 10, 3593-3606.
31. 11Clabelled peptides in tumour diagnosis with PET. Eur. J. Nucl. Med. Mol. Imaging, 2004, 31, 1653-1657.
32. 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy. J. Nucl. Med., 2009, 50, 116-122.
33. 18F-labeled BBN- RGD heterodimer for prostate cancer imaging. J. Nucl. Med., 2008, 49, 453-461.
34. Tweedle, M. F. Peptide-targeted diagnostics and radiotherapeutics. Acc. Chem. Res., 2009, 42, 958-968.
35. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J. Nucl. Med., 2006, 47, 492-501.
36. 18F]fluoride ion. Eur. J. Org. Chem., 2008, 17, 2853-2873.
37. 18F]-fluorobenzene for PET. Bioconjug. Chem., 2009, 20, 817-823.
38. 18F-labeling of peptides via nucleophilic aromatic substitution. Bioconjug. Chem., 2009, 20, 2254-2261.
39. Haubner, R.; Wester, H.-J. Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies. Curr. Pharm. Des., 2004, 10, 1439-1455.
40. Dollé, F.; Roeda, D.; Kuhnast, B.; Lasne, M.-C. Fluorine-18 chemistry for molecular imaging with positron emission tomography. In Fluorine and Health: Molecular Imaging, Biomedical Materials and Pharmaceuticals; Tressaud, A.; Haufe, G.; Eds.; Elsevier Science: Amsterdam, 2008, pp 3-65.
41. Richter, S.; Bergmann, R.; Pietzsch, J.; Ramenda, T.; Steinbach, J.; Wuest, F. Fluorine-18 labeling of phosphopeptides: A potential approach for the evaluation of phosphopeptide metabolism in vivo. Peptide Sci., 2009, 92, 479-488.
42. 18F-labeled thiol-reactive reagent N-[6-(4- [18F]fluorobenzylidene)aminooxyhexyl]maleimide. Nucl. Med. Biol., 2007, 34, 5-15.
43. 68Ga-labeled peptide. Nucl. Med. Biol., 2008, 35, 529-536.
44. 18F-label the vasoactive transmitter urotensin-II as a ligand for positron emission tomography. Nucl. Med. Biol., 2008, 35, 725-731.
45. 18F-Nmethylaminooxy-containing prosthetic group to a vinylsulfone modified peptide. J. Labelled Compd. Radiopharm., 2009, 52, 571-575.
46. 18F]Labelled peptides for positron emission tomography. Bioorg. Med. Chem. Lett., 2000, 10, 1501-1503.
47. 18F]fluoropropionyl peptides. Bioconjug. Chem., 2006, 17, 1017-1021.
48. Schweinsberg, C.; Maes, V.; Brans, L.; Blauenstein, P.; Tourwe, D. A.; Schubiger, P. A.; Schibli, R.; Garayoa, E. G. Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors. Bioconjug. Chem., 2008, 19, 2432-2439.
49. Fichna, J.; Janecka, A. Synthesis of target-specific radiolabeled peptides for diagnostic imaging. Bioconjug. Chem., 2002, 14, 3-17.
50. Wester, H.J.; Schottelius, M. Fluorine-18 labeling of peptides and proteins. In PET Chemistry - The Driving Force in Molecular Imaging; Schubiger, A. P.; Lehmann, L. Friebe, M.; Eds,; Springer: Berlin, 2007, pp. 79-111.
51. Okarvi, S. M. Recent progress in fluorine-18 labelled peptide radiopharmaceuticals. Eur. J. Nucl. Med., 2001, 28, 929-938.
52. 18F]SFB) for protein labeling. J. Labelled Compd. Radiopharm., 2008, 51, 68-71.
53. 18F. Nat. Protoc., 2006, 1, 1655-1661.
54. 18F]fluorobenzoate. Nucl. Med. Biol., 1992, 19, 275-281.
55. Fredriksson, A.; Johnstrom, P.; Stone-Elander, S.; Jonasson, P.; Nygren, P.-A.; Ekberg, K.; Johansson, B.-L.; Wahren, J. Labeling of human C-peptide by conjugation with N-succinimidyl-4- [18F]fluorobenzoate. J. Labelled Compd. Radiopharm., 2001, 44, 509-519.
56. Wester, H.J.; Hamacher, K.; Stöcklin, G. A Comparative study of n.c.a. fluorine-18 labelingof proteins via acylation and photochemical conjugation. Nucl. Med. Biol., 1996, 23, 365-372.
57. 18F]fluorocarboxylic acids. Appl. Radiat. Isot., 1994, 45, 715-727.
58. 1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: Synthesis, radiolabeling, in vitro validation and biodistribution in mice. Nucl. Med. Biol., 1994, 21, 819-825.
59. 18F]fluorobenzoate. Appl. Radiat. Isot., 2003, 59, 43-48.
60. Marik, J.; Sutcliffe, J. L. Fully automated preparation of n.c.a. 4- [18F]fluorobenzoic acid and N-succinimidyl 4-[18F]fluorobenzoate using a Siemens/CTI chemistry process control unit (CPCU). Appl. Radiat. Isot., 2007, 65, 199-203.
61. 18F]SFB). Appl. Radiat. Isot., 2005, 63, 329-332.
62. 18F]SFB). J. Labelled Compd. Radiopharm., 2009, 52, 327-330.
63. 18F]- N-succinimidyl 4-(fluoromethyl)benzoate for protein labeling. Appl. Radiat. Isot., 1994, 45, 1155-63.
64. 18F]-labeled benzylfluoride derivatives. Nucl. Med. Biol., 2000, 27, 163-168.
65. 18F]F-Py-TFP): A new prosthetic group for efficient labeling of biomolecules with fluorine-18. J. Med. Chem., 2010. (Article ASAP, DOI: 10.1021/jm9015813).
66. Kilbourn, M. R.; Dence, C. S.; Welch, M. J.; Mathias, C. J. Fluorine-18 labeling of proteins. J. Nucl. Med., 1987, 28, 462-470.
67. 18F]fluoropyridin-3-yloxy)propyl]acetamide. Bioconjug. Chem., 2004, 15, 617-627.
68. 18F for in vivo PET imaging. J. Labelled Comp. Radiopharm., 1997, 39, 319-330.
69. 18F-labelled pyridine-based alkylating agent for high yield oligonucleotide conjugation. Appl. Radiat. Isot., 2009, 67, 1670-1675.
70. Bark, S. J.; Schmid, S.; Hahn, K. M. A highly efficient method for site-specific modification of unprotected peptides after chemical synthesis. J. Am. Chem. Soc., 2000, 122, 3567-3573.
71. Carrasco, M. R.; Silva, O.; Rawls, K. A.; Sweeney, M. S.; Lombardo, A. A. Chemoselective alkylation of N-alkylaminooxycontaining peptides. Org. Lett., 2006, 8, 3529-32.
72. Carrasco, M. R.; Nguyen, M. J.; Burnell, D. R.; MacLaren, M. D.; Hengel, S. M. Synthesis of neoglycopeptides by chemoselective reaction of carbohydrates with peptides containing a novel N'methyl-aminooxy amino acid. Tetrahedron Lett., 2002, 43, 5727-5729.
73. Olberg, D. E.; Hjelstuen, O. K.; Solbakken, M.; Arukwe, J.; Karlsen, H.; Cuthbertson, A. A novel prosthetic group for siteselective labeling of peptides for positron emission tomography. Bioconjug. Chem., 2008, 19, 1301-1308.
74. de Vries, E. F. J.; Vroegh, J.; Elsinga, P. H.; Vaalburg, W. Evaluation of fluorine-18-labeled alkylating agents as potential synthons for the labeling of oligonucleotides. Appl. Radiat. Isot., 2003, 58, 469-476.
75. de Graaf, A. J.; Kooijman, M.; Hennink, W. E.; Mastrobattista, E. Nonnatural amino acids for site-specific protein conjugation. Bioconjugate Chem., 2009, 20, 1281-1295.
76. Hackenberger, A. Christian P. R.; Schwarzer, D. Chemoselective ligation and modification strategies for peptides and proteins. Angew. Chem. Int. Ed., 2008, 47, 10030-10074.
77. Kiesewetter, D. O.; Kraemer-Marek, G.; Ma, Y.; Capala, J. Radiolabeling of HER2-specific Affibody molecule with F-18. J. Fluorine Chem., 2008, 129, 799-806.
78. 18F-radiochemistry: syntheses and applications. Mini-Rev. Org. Chem., 2007, 4, 317-329.
79. Hultsch, C.; Berndt, M.; Bergmann, R.; Wuest, F. Radiolabeling of multimeric neurotensin(8-13) analogs with short-lived positron emitter fluorine-18. Appl. Radiat. Isot., 2007, 65, 818-826.
80. 18F. J. Labelled Compd. Radiopharm., 1989, 26, 287-289.
81. 18F]fluoropyridinebased maleimide reagent for the labeling of peptides and proteins. Bioconjugate Chem., 2005, 16, 406-420.
82. 18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of v 3 integrin expression. J. Nucl. Med., 2006, 47, 1172-1180.
83. 18F-Fluorothiols: A new approach to label peptides chemoselectively as potential tracers for positron emission tomography. Bioconjugate Chem., 2004, 15, 1447-1453.
84. Mamat, C.; Ramenda, T.; Wuest, F. R. Recent applications of click chemistry for the synthesis of radiotracers for molecular imaging. Mini-Rev. Org. Chem., 2009, 6, 21-34.
85. Glaser, M.; Robins, E. G. Click labelling in PET radiochemistry. J. Labelled Compd. Radiopharm., 2009, 52, 407-414.
86. Marik, J.; Sutcliffe, J. L., Click for PET: rapid preparation of [18F]fluoropeptides using CuI catalyzed 1,3-dipolar cycloaddition. Tetrahedron Lett., 2006, 47, 6681-6684.
87. 18F]Fluoroethylazide for positron emission tomography. Bioconjug. Chem., 2007, 18, 989-993.
88. 18F-labeling of RGD Peptides and microPET imaging of tumor integrin v 3 expression. Bioconjug. Chem., 2007, 18, 1987-1994.
89. 18f-labeled neurotensin(8-13) via copper-mediated 1,3-dipolar [3+2]cycloaddition reaction. Lett. Drug Des. Discov., 2007, 4, 279-285.
90. Vaidyanathan, G.; White, B. J.; Zalutsky, M. R. Propargyl 4- [18F]fluorobenzoate: a putatively more stable prosthetic group for the fluorine-18 labeling of biomolecules via click chemistry. Curr. Radiopharm., 2009, 2, 63-74.
91. 18F]FPyKYNE, a fluoropyridine-based alkyne reagent designed for the fluorine-18 labeling of macromolecules using click chemistry. J. Labelled Compd. Radiopharm., 2008, 51, 336-342.
92. Buncel, E.; Um, I.-H. The alpha -effect and its modulation by solvent. Tetrahedron, 2004, 60, 7801-7825.
93. 18F-labeled RGD and ocreotide analogs. J. Nucl. Med., 2004, 45, 892-902.
94. 18F-fluorinated aldehydes. Nucl. Med. Biol., 2006, 33, 173-183.
95. Kalia, J.; Raines, Ronald T. Hydrolytic stability of hydrazones and oximes. Angew. Chem. Int. Ed., 2008, 47, 7523-7526.
96. Poethko, T.; Schottelius, M.; Thumshirn, G.; Herz, M.; Haubner, R.; Henriksen, G.; Kessler, H.; Schwaiger, M.; Wester, H.-J. Chemoselective pre-conjugate radiohalogenation of unprotected monoand multimeric peptides via oxime formation. Radiochim. Acta, 2004, 92, 317-327.
97. 18F]fluorobenzaldehyde via oxime chemistry. Mol. Imaging Biol., 2008, 10, 177-81.
98. 18F]fluoroethylazide, and S-alkylation with [18F]fluoropropanethiol. Amino Acids, 2008, 37, 717-724.
99. 18F-labeling of the protein hormone leptin using a general two-step ligation procedure. J. Am. Chem. Soc., 2008, 130, 9106-9112.
100. 18F]fluorinated aldehyde-containing prosthetic groups. Bioconjug. Chem., 2008, 19, 951-957.
101. 18F-AH111585 in breast cancer patients. J. Nucl. Med., 2008, 49, 879-886.
102. Haubner, R.; Wester, H.-J.; Burkhart, F.; Senekowitsch-Schmidtke, R.; Weber, W.; Goodman, S. L.; Kessler, H.; Schwaiger, M. Glycosylated RGD-containing peptides: Tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J. Nucl. Med., 2001, 42, 326-336.
103. Kuijpers, B. H. M.; Groothuys, S.; Soede, A. C.; Laverman, P.; Boerman, O. C.; van Delft, F. L.; Rutjes, F. P. J. T. Preparation and evaluation of glycosylated arginine-glycine-glutamate (RGD) derivatives for integrin targeting. Bioconjugate Chem., 2007, 18, 1847-1854.
104. 18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. Bioconjugate Chem., 2004, 15, 61-69.
105. 18F-glycosylation of amino acids. J. Labelled Compd. Radiopharm., 2005, 48, 701-719.
106. 18F-glycosylation of peptides. Bioconjugate Chem., 2007, 18, 254-262.
107. 18F-labeling of peptides and proteins. Bioconjugate Chem., 2008, 19, 1202-1210.
108. 18F-glycopeptides as effective imaging probes for positron emission tomography. Angew. Chem. Int. Ed., 2010, 49, 976-979.
109. 18F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK). Eur. J. Nucl. Med. Mol. Imaging, 2009, 36, 1469-1474.
110. 18F]FDG). Bioorg. Med. Chem. Lett., 2009, 19, 5426-5428.
111. 18F]FDG. Bioconjug. Chem., 2009, 20, 432-436.
112. 18F-labeling. J. Am. Chem. Soc., 2005, 127, 13094-13095.
113. Ting, R.; Harwig, C.; auf dem Keller, U.; McCormick, S.; Austin, P.; Overall, C. M.; Adam, M. J.; Ruth, T. J.; Perrin, D. M. Toward [18F]-labeled aryltrifluoroborate radiotracers: In Vivo positron emission tomography imaging of stable aryltrifluoroborate clearance in mice. J. Am. Chem. Soc., 2008, 130, 12045-12055.
114. 18F-radiolabeling of peptides for PET imaging. Angew. Chem., Int. Ed., 2008, 47, 4922-4925.
115. 18F-labeled silicon-based PET tracers and their hydrolytic stability: Experimental data and theoretical calculations. Chem. Eur. J., 2009, 15, 3736-3743.
116. 18F-Labeling of N-amino-oxy derivatized peptides. Bioconjug. Chem., 2007, 18, 2085-2089.
117. 18F] FA-SH) labeled rat serum albumin for blood pool imaging with PET. Bioconjug. Chem., 2009, 20, 317-321.
118. 18F-Labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks. Bioconjug. Chem., 2008, 19, 1871-1879.
119. 18F radiolabeling for PET. J. Nucl. Med., 2009, 50, 991-998.